SNPHY(SNPHY)
SNPHY
No analyst ratings available
No analyst price targets available for SNPHY
Analyst coverage may not be available for this symbol
No recent analyst actions
| Metric | FY2027E | FY2028E |
|---|---|---|
| Revenue Avg | $312.64B | $313.63B |
| Low | $301.84B | $293.30B |
| High | $322.51B | $335.50B |
| EBITDA Avg | $93.62B | $93.92B |
| Low | $90.39B | $87.83B |
| High | $96.58B | $100.47B |
| EBIT Avg | $79.04B | $79.29B |
| Low | $76.31B | $74.15B |
| High | $81.53B | $84.81B |
| Net Income Avg | $40.01B | — |
| Low | $38.22B | — |
| High | $41.65B | — |
| EPS Avg | $121.85 | — |
| Low | $116.38 | — |
| High | $126.85 | — |
| Analysts (Rev / EPS) | 5 / 1 | 9 / — |
| Metric | Q3 2026 |
|---|---|
| Revenue Avg | $73.09B |
| Low | $72.20B |
| High | $73.97B |
| EBITDA Avg | $21.89B |
| Low | $21.62B |
| High | $22.15B |
| EBIT Avg | $18.48B |
| Low | $18.25B |
| High | $18.70B |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 3 / — |